2016 Sponsors & Exhibitors 



BD is a leading medical technology company that partners with customers and stakeholders to address many of the world’s most pressing and evolving health needs. Our innovative solutions are focused on improving medication management and patient safety; supporting infection prevention practices; equipping surgical and interventional procedures; improving drug delivery; aiding anesthesiology and respiratory care; advancing cellular research and applications; enhancing the diagnosis of infectious diseases and cancers; and supporting the management of diabetes. We are more than 45,000 associates in 50 countries who strive to fulfil our purpose of “Helping all people live healthy lives” by advancing the quality, accessibility, safety and affordability of healthcare around the world. In 2015, BD welcomed CareFusion and its products into the BD family of solutions. For more information on BD, please visit bd.com.




Terumo is one of the world’s leading medical technology companies and operates in more than 160 nations. Terumo, founded in 1921, develops, manufactures and distributes a broad range of world-class medical devices including the supply of drug delivery/injection devices to the pharmaceutical industry.

Pharmaceutical Solutions

Terumo Pharmaceutical Solutions offers the pharmaceutical and biotechnology industry unique solutions in medical technology. In addition to offering our valued products, our specialized team also provides customized and dedicated solutions designed to meet your specific requirements.

Pall Life Sciences

Pall Life Sciences develops, manufactures, sells and services products to customers that conduct research in the life sciences field, or in the production of therapeutic biologicals, drugs, vaccines and other biopharmaceuticals in-vitro diagnostic and healthcare markets. The Biopharmaceuticals group within Pall Life Sciences addresses the sub-market segments like biotechnology, vaccines, plasma, active pharmaceutical ingredients (API) and the formulation/filling. For each sub-market, Pall provides a broad range of advanced cell culture, filtration and separation solutions for each critical stage from drug development to production and provides validation services to assist drug manufacturers through the regulatory process and onto the market.


Novo Nordisk website

Novo Nordisk Pharmatech A/S was established in 1949 as FeF Chemicals, acquired by Novo Nordisk in 1986 and has been part of the pharmaceutical group since then. On 1 September 2015 the company’s name was changed to Novo Nordisk Pharmatech A/S.  It is the leading worldwide supplier of recombinant insulin for cell growth media and pharmaceutical grade quaternary ammonium compounds (Quats) for the pharmaceutical, biopharmaceutical and personal care industries.


Watson-Marlow Fluid Technology Group (WMFTG) is the world leader in niche peristaltic pumps and associated fluid path technologies for the food, pharmaceutical, chemical and environmental industries. Comprising nine established brands, each with their own area of expertise, but together offering our customers unrivalled solutions for their pumping and fluid transfer applications


Operating in Asia for 16 years, Almac launched our Asia Pacific Headquarters in Singapore 2015, expanding our physical presence within the Asia Pacific region and expanding our full clinical supply chain management solution across the region. We’re fully staffed and equipped to support trials of any size and complexity. We support regionally formed trials as well as Asia-Pacific elements of fully global studies. Visit us at stand no. 5 to find out more.

Contact Us:

Almac Pharmaceutical Services Pte. Ltd. (Asia Pacific Headquarters) | 9 Changi South Street 3 #01-01 (S) 486361 | Info@almacgroup.com | +65 6309 0728

GE Logo

The Life Sciences business of GE Healthcare exists to enable and accelerate molecular and precision medicine. We do this by helping our customers discover, make and use new medicines.

Healthcare needs more precise diagnoses and treatments to improve patient outcomes, address the globally rising incidence of lifestyle and chronic diseases, and help reduce the $350 billion wasted each year on poorly-targeted medicines.

We empower researchers with the innovative tools and analytics to research and develop tomorrow’s therapeutics.

We drive productivity for the biopharmaceutical industry and help create manufacturing capacity in under-served markets.

We enable increasingly accurate diagnoses by providing advanced in vivo imaging agents & in vitro diagnostics.

We are helping create the future of regenerative medicine and cell therapy with customers by providing novel tools, technologies and methods.

We work on the things that matter to become trusted partners with our customers, combining our deep expertise, integrity, and heritage in diagnostics and biotechnology with an extensive global network and strength in infrastructure and services.

We are a $4.0 billion business of GE Healthcare serving researchers, pharmaceutical companies, and clinicians.



JHL KUBio story:http://kubio.campaignhosting.se/#vision


Gold Sponsor

Gold Sponsor

Tech Showcase

Tech Showcase